NASDAQ:ETON | Free Cash Flow | Eton Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$7.41M$75,000.00$7.33M471.69%
2025-12-31-$11.55M$49,000.00-$11.6M-782.20%
2025-03-31$2.09M$0.00$2.09M
2024-12-31-$765,000.00$12,000.00-$777,000.00
2024-03-31-$2.47M$14,000.00-$2.49M
2023-12-31$387,000.00$0.00$387,000.00
2023-03-31-$1.55M$0.00-$1.55M
2022-12-31$2.84M$12,000.00$2.83M310.09%
2022-03-31$1.22M$15,000.00$1.21M
2021-12-31-$5.12M$4,000.00-$5.12M-492.88%
2021-03-31$3.72M
2020-12-31-$7.18M$44,000.00-$7.23M
2020-03-31-$7.22M$4,000.00-$7.22M
2019-12-31-$3.85M$34,000.00-$3.88M
2019-03-31-$6.77M$388,000.00-$7.16M
2018-12-31-$1.77M$54,000.00-$1.83M
2018-03-31-$1.85M$91,000.00-$1.94M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$10.52M$333,000.00$10.19M
2024-12-31$969,000.00$26,000.00$943,000.00
2023-12-31$6.82M$0.00$6.82M
2022-12-31$4.82M$38,000.00$4.78M
2021-12-31-$4.72M$9,000.00-$4.73M
2020-12-31-$22.35M$50,000.00-$22.4M
2019-12-31-$18.03M$1.1M-$19.12M
2018-12-31-$8.15M$236,000.00-$8.38M